Market Insights Health Medical Technology

Medical Devices - Central & Western Europe

Central & Western Europe

The Medical Devices market market in Central & Western Europe is anticipated to achieve a revenue of US$96.19bn in 2024.
Among the various markets, Cardiology_Devices is projected to be the largest with a market volume of US$13.60bn in the same year.
It is expected that the revenue will experience a Compound Annual Growth Rate (CAGR 2024-2029) of 5.01%, leading to a market volume of US$122.80bn by 2029.
When compared globally, the United States is expected to generate the highest revenue, reaching US$179.80bn in 2024.
Germany is leading the way in Central & Western Europe in the development and adoption of innovative medical devices for the healthcare industry.

Key regions: Germany, Spain, Japan, United Kingdom, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Devices market in Central & Western Europe is experiencing steady growth and development, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Medical Devices market in Central & Western Europe are shifting towards more advanced and innovative products. Customers are increasingly demanding medical devices that are technologically advanced, user-friendly, and provide accurate and reliable results. This preference for advanced technology is driving the market towards the development of more sophisticated medical devices that cater to the specific needs of patients and healthcare professionals. Trends in the market include the increasing adoption of digital health solutions and the growing demand for home healthcare devices. Digital health solutions, such as telemedicine and remote patient monitoring, are gaining popularity in Central & Western Europe as they offer convenient and cost-effective healthcare options. Additionally, the rising aging population in the region is driving the demand for home healthcare devices, which allow patients to receive medical care and monitoring in the comfort of their own homes. Local special circumstances in Central & Western Europe also contribute to the development of the Medical Devices market. The region has a well-established healthcare infrastructure and a high level of healthcare expenditure, which creates a favorable environment for the growth of the market. Furthermore, the presence of leading medical device manufacturers and research institutions in countries like Germany and Switzerland further enhances the market's development. Underlying macroeconomic factors, such as favorable government policies and increasing healthcare expenditure, also play a significant role in the growth of the Medical Devices market in Central & Western Europe. Governments in the region are actively promoting the adoption of medical devices to improve healthcare outcomes and reduce healthcare costs. Additionally, the increasing healthcare expenditure in the region is providing a boost to the market by creating a favorable investment environment for medical device manufacturers. Overall, the Medical Devices market in Central & Western Europe is developing at a steady pace, driven by customer preferences for advanced technology, market trends such as digital health solutions and home healthcare devices, local special circumstances including a well-established healthcare infrastructure, and underlying macroeconomic factors such as favorable government policies and increasing healthcare expenditure.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.